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Introduction
Severe complications at delivery are under-researched (1) . The reasons for this are low numbers, interactions between different severe complications, problems of validity in reporting, and the need for appropriate denominators. In the Nordic Obstetric Surveillance Study (NOSS) we addressed these issues by simultaneous collection of information on four rare severe complications at delivery: complete uterine rupture, peripartum hysterectomy, abnormally invasive placenta (AIP), and severe blood loss at delivery ( Table 1 ). The NOSS project is a populationbased study that started in 2009 as a collaborative effort between obstetricians and the national birth registers in the five Nordic countries: Denmark, Finland, Iceland, Norway, and Sweden.
There is a continuum from severe maternal morbidity to maternal mortality. The study of women at high risk of dying ("maternal near-miss") can therefore provide valuable information on the management of obstetric emergencies in comparison with women who actually die, and this may eventually lead to improvements in the content of care. The World Health Organization has suggested that the rate of severe maternal morbidity should be used as an indicator for obstetric care in high-resource countries, rather than maternal mortality (2) .
This article presents the rates of complete uterine rupture, peripartum hysterectomy, AIP, and severe blood loss at delivery and assesses possible risk factors noted in the Nordic countries.
Material and methods
Women with complete uterine rupture, peripartum hysterectomy, AIP, and severe blood loss at delivery measured by multiple blood transfusions (>5 units of red blood cells) were included from April 2009 to August 2012, with slightly different study periods between the countries ( Table 2) . A total of 135 maternity units participated. In Denmark, Finland, and Iceland all units participated, but in Norway and Sweden some units did not collect data, accounting for 12-21% of the background population ( Table 2 ). All maternity units were invited, except in Norway, where 26 units with <500 deliveries/ year were not included.
Trained clinicians at the Nordic maternity units reported cases by unified electronic data collection forms (http://www.enalyzer.dk), paper data collection forms, or a combination of both. Specific data forms were elaborated in consensus in the Nordic Federation of Societies of Obstetrics and Gynecology study group and detailed information about the collected variables can be found at http://www.NOSS.nu.
Individualized and anonymized data from Denmark, Iceland, and Norway were stored in an electronic database in Denmark, whereas data from Finland and Sweden were stored in local databases. Regular reminders were sent to the clinicians at the participating clinics to ensure complete reporting. Validation of the reported numbers was done by retrieving the relevant International Classification of Diseases, 10th revision codes on diagnoses and Nordic Medico-Statistical Committee Classification of Surgical Procedure codes (http://www.nordclass.se/ ncsp_e.htm) from the medical birth registers, the hospital discharge registers, and the transfusion databases in each country. Cases recorded in the registers but not reported to NOSS were confirmed by the hospitals and the requested data for the true cases were then reported retrospectively. In this way we cross-checked the registers and the reported information. In Norway we were not allowed to collect case reports with person-identifiable information and so it was not possible to compare this with the national registers. Therefore the clinicians were asked to compare the reported cases with information from the local hospital database to cross-check the reported information.
In Denmark and Iceland all cases with blood transfusions are recorded in national databases (http:// www.dtdb.dk, http://www.blodbankinn.is) and we used this information to validate cases of severe blood loss at delivery. In Finland and Norway, information about transfusion is stored in local blood banks and is not easily accessible at a national level. Hence, validation of the reported cases of severe blood loss at delivery was not possible. Sweden did not collect information on women with severe blood loss at delivery as isolated events and Sweden was excluded from the denominator for this variable. The estimated blood loss at delivery and the number of blood transfusions were described for all cases of uterine rupture, peripartum hysterectomy, and AIP. The background population (denominators) otherwise comprised all women who delivered in the participating clinics during the study period. Data on denominators were collected from the Nordic medical birth registers and the hospital discharge registers (3, 4) .
Ethical approval was obtained in each country according to national legislation. In Denmark, the study was approved by the Danish Data Protection Agency, in Finland by the Ministry of Social Affairs and Health, in Sweden by the Central Ethical Board for Medical Research, in Norway by Regional Ethical committees, and in Iceland by the Directorate of Health and the National Bioethics Committee.
Statistical analysis
Data were managed in SAS ENTERPRISE GUIDE 9.4 (SAS Institute, Cary, NC, USA) and MICROSOFT OFFICE, EXCEL 2010 (Microsoft, Redmond, WA, USA). Prevalence rates are presented per 10 000 deliveries with exact 95% CI. Risks are presented as the odds of having a complication belonging to a specific subgroup, such as for the age group 30-34 years. Chi-squared and Fisher's exact tests were used to compare proportions and associations 
Results
The NOSS study included 605 362 deliveries during a 2year period, corresponding to 91% of all Nordic deliveries (n = 666 306). A total of 1019 cases were reported with one or more complications (19/10 000 deliveries). Severe blood loss at delivery was reported for 500 women (11.6/10 000 deliveries), complete uterine rupture was reported in 337 women (5.6/10 000 deliveries), AIP in 279 women (4.6/10 000 deliveries), and peripartum hysterectomy in 211 women (3.5/10 000 deliveries) ( Table 2 ). The rates varied significantly between the Nordic countries: Finland had a significantly higher rate of complete uterine rupture and peripartum hysterectomy than Denmark, Norway, and Sweden ( Table 2) . Denmark had a significantly higher rate of AIP than the other Nordic countries and a significantly higher reported rate of severe blood loss at delivery than Finland. One maternal death was registered among the 1019 reported cases in NOSS.
One-fourth of the women had more than one complication. Of women with complete uterine rupture, 16% had other complications, most frequently severe blood loss at delivery (7%) or severe blood loss at delivery and peripartum hysterectomy (5%). AIP with other complications was reported in 49% of the cases, almost exclusively hemorrhage and hysterectomy (23%), or each of these alone (16% vs. 10%). Complete uterine rupture was seen in only 1% of all cases with AIP. Women with peripartum hysterectomy had other complications in 92% of the cases: 37% had severe blood loss at delivery, 13% had AIP, and 30% had a combination of both. Severe blood loss at delivery affected about 53% of all the women included and was the complication most often combined with any of the other complications (87%) ( Figure 1 ).
More than half of all Nordic parturients during the study period had one or more previous deliveries, were between 25 and 34 years old and had a normal body mass index (BMI) (18.5-24.9 kg/m 2 ). Danish women were on average slightly older and Swedish women had a slightly higher BMI than women in the other countries. More than 75% of the parturients had a spontaneous vaginal delivery at term. The total rate of cesarean section (CS) was 18%, highest in Denmark (21%), and lowest in Iceland (15%). A history of previous CS was reported in 9% of all women and of these, 77% had an intended vaginal delivery with an estimated success rate of 64%. More details of the background population are shown in Table 3 .
Age, number of previous deliveries, previous CS, mode of delivery, induction of labor, and gestational age were associated with all the studied complications. BMI was not associated with AIP and multiple pregnancy was not associated with complete uterine rupture (Table 4) .
Approximately 60% of all cases were collected prospectively. In Sweden, all cases were reported prospectively from the clinicians and no additional cases were retrieved from the registers. In Finland about 80% and in Denmark and Norway about 50% and 60% of cases, respectively, were reported prospectively by clinicians. In Iceland all cases were collected retrospectively by use of the national registers. In Denmark some of the cases reported to NOSS were not reported with the relevant codes to the national health registers. In 13 of 78 (17%) reported cases of complete uterine rupture, 39 of 126 (31%) of AIP cases, and five of 50 (10%) cases of peripartum hysterectomy, the registration of the event was absent in the Danish National Discharge Register. From the Danish National Discharge Register we identified 377 women with a diagnosis of uterine rupture of whom 236 were observational diagnoses not confirmed clinically and 76 were incomplete ruptures with intact fetal membranes and/or peritoneum. AIP was registered in 129 women, where 12 were not confirmed by the medical records and 28 did not meet our definition. Peripartum hysterectomy was registered in 53 cases, where six women first had a hysterectomy after 7 days postpartum and two women had no peripartum hysterectomy at all. All cases that were not registered both into the NOSS project and in the national health registers were double-checked by asking the local clinician to re-confirm the case from the medical records and if confirmed, the maternity unit was asked to report the case correctly to the register.
Discussion
In this Nordic collaboration we found that complete uterine rupture, AIP, peripartum hysterectomy, and severe blood loss at delivery were associated with maternal age, parity, previous CS, mode of delivery, induction of labor, and gestational age, whereas BMI and multiple pregnancy were not associated with AIP and complete uterine rupture, respectively. The results indicate that increasing maternal age, BMI, and parity as well as preterm delivery increases the risk of complications. Likewise previous CS, multiple pregnancy, labor induction, and trial of labor after CS seemed to be associated with a higher risk of complications, but as the results are presented as crude odds, more analyses are needed to confirm such actual associations; the NOSS group are continuously working to publish new results and guidance to management of the studied complications. The NOSS study covered 91% of all Nordic deliveries in an approximately 2-year period for each country. Our results are based on a relatively high number of cases with severe obstetric maternal complications, which it is difficult to collect in a smaller population. A major strength of this study is the consecutive detailed data collection from medical records combined with registerbased identification of cases and validation of reported cases. This is an advantage compared with other small studies based on prospective data collection (5, 6) , register-based studies (3, 7, 8) , and even controlled prospective data collections like the UK obstetric surveillance system (9) . The simultaneous collection of data on conditions associated with severe blood loss at delivery, and the collection of data on multiple transfusions, implied that we could cross-check and identify severe cases of uterine rupture, peripartum hysterectomy, and AIP that were not reported initially. A limitation of the study is that the material was not complete and a few medium and large maternity units from Sweden and Norway did not participate in the project, or reported lower rates than expected. This may result in an underestimation of the rates, but since severe complications tend to accumulate in highly specialized units from which reports were received, the data collected should approach completeness.
Despite efforts to unify data collection, national differences in the methods of data collection might explain some of the differences in the results. The possibility to validate and seek out cases with massive transfusions from the registers in Denmark and Iceland are expected Table 3 . to give a more exact estimate of the NOSS cases, including the rate of severe blood loss at delivery. Likewise the Danish study group identified cases of AIP from the registers by combining the procedure-code for manual placental removal with information of blood transfusion within 48 h postpartum. This, and a significantly higher CS rate in Denmark, could possibly explain the higher rates of severe blood loss at delivery and of AIP observed in Denmark. Data from medical records on major complications and interventions, including surgery, are considered valid, whereas minor procedures may have been incomplete or insufficiently described in the medical records. The use of the registers to obtain population-based background information, implies that we have information on a very large number of parturients. The available information in the registers, however, limits the research questions that can be addressed, especially regarding risk factors. Register-based denominators, on the other hand, provide a valid population-based estimate of rates.
In this study we had only one maternal death. According to personal correspondence with the Nordic Maternal Mortality Collaboration, there are about 10 direct maternal deaths in the Nordic countries each year. About 10% of these will be related to hemorrhage, which would give an expected number of about two to three maternal deaths in the NOSS cohort. The last report from MBBRACE-UK revealed a rate of 0.59 maternal deaths related to hemorrhage per 100 000 deliveries in the UK from 2009 to 2011, which could equate to an expected number of three to four maternal deaths in a population of our size (10) . As maternal death is a very traumatic experience for the departments involved, we do not believe that maternal death was underreported. The reason for the low number is probably that maternal deaths are not evenly distributed over time and more deaths due to hemorrhage might have occurred outside our study period.
In comparison with other population-based studies, we found that the rate of peripartum hysterectomy was compatible with rates in other northern European countries. A prospective study from the Netherlands reported a rate of 3.3/10 000, and in the UK 4.1/10 000 deliveries (11, 12) . In the USA (7.7/10 000), Canada (8.0/10 000) and Italy (8.6/10 000) higher rates of peripartum hysterectomy have been reported (8, 13, 14) . A previous Danish population-based study from 1995 to 2004 showed a rate of 2.4/10 000, comparable with the rate of 3.0/10 000 in this study (15) . The observed rate differences may reflect different populations or management of complications leading to peripartum hysterectomy. A recent Dutch study suggests that the low rate of hysterectomies among women with major obstetric hemorrhage observed in the Table 4 . Netherlands (3.0/10 000 deliveries) could partly be explained by the frequent use of arterial embolization, which prevented peripartum hysterectomy in half of the studied cases (16) . It is our impression that arterial embolization is not frequently used in the Nordic countries and we cannot say whether embolization would have changed the peripartum hysterectomy rate. We think there is a need for further in-depth analysis including audit and cross-country comparisons of risk profiles and management of the complications leading to peripartum hysterectomy to decide how peripartum hysterectomy could be made potentially avoidable.
The complete uterine rupture rates were compatible with rates from population-based studies in the Netherlands and Israel at 5.9 and 6.0/10 000 deliveries, respectively (17, 18) . The UK and Canada have reported very low rates at 1.9 and 1.6/10 000 deliveries, respectively (7, 19) . As uterine rupture is known to be associated with previous CS, the difference in rates could be explained by different rates of parturients with previous CS and trial of labor or vaginal birth after CS situations. Studies from the Netherlands and Canada report a previous CS rate of about 10%, corresponding to the highest rates seen in the Nordic countries (17, 20, 21) . In Canada, the UK, and the Netherlands, the rates of trial of labor after a previous CS are reported to be 39, 52 and 72%. Rate of successful vaginal birth after CS were 27, 63 and 54%, respectively. Except for the Netherlands, these rates are much lower than the corresponding rates in our study, where trial of labor after a previous CS ranged from 65 to 80% with a successful vaginal birth after CS ranging from 40 to 75% (21) (22) (23) . This may indicate that the higher rates of women trying to deliver vaginally after previous CS in the Netherlands and the Nordic countries lead to higher rates of complete uterine rupture.
Rates of AIP are reported with a very wide range. Two old studies from California and Israel reported rates of 4 and 90/10 000 deliveries (5, 6) . In a more recent study from the UK a rate of 1.7/10 000 deliveries was reported (24) . The wide range may reflect that placental disorders are a heterogeneous group. There is an ongoing discussion among clinicians of the diagnostic criteria for AIP. Our data represent a broader spectrum from partly adherent placenta in women delivering vaginally, to the most severe cases of placenta percreta. Due to this we expected and verified a higher rate in our study compared with studies with stricter definitions. To be able to compare rates worldwide, there is a current call for a unified international definition of AIP (http://www.ewaip.org).
The study of severe blood loss at delivery is also challenged by a lack of uniform international definitions. A Scottish study reported a rate of 19/10 000 deliveries (definition: transfusion of ≥5 red blood cell units), and a Dutch study reported 61/10 000 deliveries (definition: ≥4 red blood cell units) (25, 26) . The difference in transfusion rates may reflect diverse risk factors, definitions, and clinical management in the populations, but they may also indicate variations in the definition of the complications. There is a need for uniform definitions and cut-off values to ease international comparisons of maternal health as suggested by the CROWN initiative (27) .
The risk associations identified in this study support results from several other studies. Fitzpatrick et al. showed increased maternal age and previous CS to be risk factors for placenta accreta or percreta, but did not find any relation between BMI or multiparity (24) . Maternal age and previous CS were also risk factors in studies by Miller et al. and Gielchinsky et al. (5, 6) . The latter reported also a relation between multiple pregnancy and increased parity as risk factors for AIP.
Ronel et al. identified increased risk of complete uterine rupture in women with previous CS, preterm delivery, and high parity (18) . In women with previous CS, Fitzpatrick et al. (24) showed an increased risk of complete uterine rupture after two or more previous CS, with intended vaginal delivery after CS and in cases with induced and/or augmented labor. For the small fraction of women with complete uterine rupture without a previous CS, the risk was also related to maternal age. For these women, there was no risk difference in relation to BMI, parity, or multiple pregnancy (19) . A high BMI, multiple pregnancy, higher parity, previous CS, preterm delivery, and CS were associated with higher risk for peripartum hysterectomy in previous studies (8, 12, 13) . Vaginal birth after CS was associated with a higher risk of peripartum hysterectomy (12, 13) .
In conclusion, NOSS provides solid population-based estimates of the rates and risk factors of peripartum hysterectomy, complete uterine rupture, AIP, and severe blood loss at delivery in the Nordic countries. With detailed information about medical history, management of labor, and complications during labor, we were able to perform cross-national audits to describe a variety of emergency situations and identify typical cases at risk. This may lead to new research hypotheses. It is important that obstetricians retain a proper awareness of the rarity and severity of these complications. It is equally important that obstetricians maintain an emphasis on pregnancy and childbirth as a normal event, and at the same time are mentally prepared for emergency actions when needed. Due to the rarity of these complications, individual experience is usually insufficient and there is a need for educational efforts and organizational measures to ensure optimal handling of these serious complications when they occur.
